Kirloskar Brothers Ltd.: Q4FY17 Result Update

Jan-16 Feb-16 Mar-16 Apr-16 May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 Edelweiss Investment Research Kirloskar Brothers Ltd.: Q4FY17 Result Update Profitability continues to improve CMP INR 254 Target INR 308 Rating: BUY Upside: 21% Kirloskar Brothers Ltd (KBL) reported healthy set of quarterly numbers with sales and net profits growth of 13.7% and 8.2% respectively. Traction in project execution including that of legacy projects enabled closure of various old sites, the segment grew at 23% on yoy basis with EBIT margin improving by 560bps to 7.5% in Q4FY17. Undeer products business, competition weighed down the growth and profitability with segment growing at only 11% on yoy basis with margin reduction by 240bps to 12.8%. On standalone basis, EBIDTA margins improved by 170bps to 7.1%. International segment suffered because of pound depreciation and slowdown in offshore oil orders. But order booking has seen strong traction in both domestic and international subs growing by 13.5% and 765% (base impact) respectively. The management is bullish on capex momentum in domestic sectors like refineries, nuclear power, irrigation, and municipalties. While in the international busienss, SPP relies now more on onshore oil, desalination, and fire pumps. Products business Improved demand but competition intensifying KBL s products business grew at 11% on yoy basis to INR 421cr. Growth has been slightly below our expectation as the industrial business is yet to gain helthy momentum. Small pumps business grew by 13% which has negated imapcts of demonetisation. Industry has been growing at 8-9% amongst which many unorganised players are resorting to price competition leading to margins pressure. We believe product margins will remain marginally lower than 13% on EBIT level till recovery of industrial products business. The management continues to remain bullish on agri/housing/industry related small pumps. KBL has started with channel financing of its distributors and has also invested in automation of payment collection systems. Projects vertical Closure of old projects, execution picking up KBL managed to financially close 17 projects including the legacy projects during the quarter. The segment grew at healthy 23% durign the quarter due to better execution. During the year, the company has provided for INR28cr for expected losses in projects and now company is confident of not incurring any more losses in the segment. Overall profitability of this segment should improve drastically from hereon as the order backlog of INR15bn is tilted more towards recently won packaged product orders rather than legacy orders. Legacy orders in Telangana are also seeing execution momentum as the govt is looking to complete these projects before state elections in 2019. During this year, the company recovered net retention money of INR 26cr. Salil Utagi Research Analyst Salil.utagi@edelweissfin.com Debashish Mazumdar Research Analyst Debashish.mazumdar@edelweissfin.com Bloomberg: KKB:IN 52-week range (INR): 298 / 117 Share in issue (cr): 7.95 M cap (INR cr): 1,969 Avg. Daily Vol. BSE/NSE :( 000): 75 International business suffered due to business slowdown and currency depreciation Order book picking up SPP pumps de-grew by almost 17% during the quarter as lower starting order backlog and pound depreciation impacted the business. SPP UK also suffered from mark to market loss of INR 12cr, which will be reversed as and when orders are dispatched in next 3 months. Order inflow has picked up in the last 2 quarters at INR 266cr and INR 329cr respectively providing respectable opening order backlog of INR 623cr. Even though business remains challenging in UK, company s South East Asia and American operations are expected to provide stable growth in the next 2-3 years Public, 34.6 Promoter, 65.4 Valuation: Maintain BUY with revised TP of INR 308 At the current price of INR 254, KBL s is trading at 12.7x FY19E P/E multiple. We believe company s leading market share and capabilities will enable it to grow substantially above industry growth while maintaining strong balance sheet. We are accounting for improving profitability of projects business with upward revision in profit estimates. We re-iterate our BUY recommendation valuing the stock at same PE multiple of 15x on revised FY19E EPS of INR 20.5 arriving at target price of INR 308. Year to March (INR Crs.) Q4FY17 Q4FY16 %Chg. YoY Q3FY17 %Chg. QoQ FY17* FY18E* FY19E* Net Rev enues (incl Op. Inc.) 575 506 14 433 33 2,471 2,859 3,146 % Growth (yoy) 16 10 EBITDA 41 28 49 19 115 158 229 333 % Growth (yoy) 45 45 Adjusted Net profit 15 18-14 2 612 61 82 163 Adjusted Diluted EPS 1.9 2.3-14 0 612 7.7 10.3 20.5 Diluted P/E (x) 33.0 24.6 12.4 EV/EBITDA (x) 13.3 9.2 6.1 RoACE (%) 6.9 10.4 18.1 *consolidated 180 160 140 120 100 80 60 40 Kirloskar Brothers Sensex Date: 25 th May 2017 1 GWM/Edelweiss Investment Research

Kirloskar Brothers Ltd. Q4FY17 Result Highlights Year to March (INR cr) Q4FY17 Q4FY16 %Change Q3FY17 %Change FY17 FY16 %Change Net Revenues (incl Op. Inc.) 575 506 13.7 433 32.7 1,735 1,639 5.9 Raw Materials Cost 328 302 8.8 280 17.1 999 990 0.9 Gross Profit 247 204 20.8 153 61.5 736 649 13.5 Operating Expenses 206 177 16.5 134 53.8 630 583 8.0 EBITDA 41 28 48.8 19 115.3 106 66 61.8 EBITDA margin 7.1 5.4 4.4 62.2 6.1 4.0 52.8 Depreciation 9 10 (10.3) 9 (4.9) 40 41 (2.8) Other income 6 7 (14.8) 2 137.8 18 21 (12.3) Net finance expense 7 11 (34.5) 9 (18.4) 32 38 (17.5) Profit before tax 31 13 127.7 3.4 790.4 53 7 612.8 Provision for taxes 14-2 NA 1 968.0 20-3 (709.3) Reported Net profit 17.0 15.7 8.2 2.2 685.2 33.0 11 205.6 Other comprehensive income 0 2 NA 0 NA -1 0 Total comprehensive income 15.4 18.0 (14.4) 2.2 612.0 31.9 10.8 195.0 As % of net revenues COGS 57 60 65 57.6 60.4 Operating expenses 36 35 31 36.3 35.6 EBITDA 7.1 5.4 4.4 6.1 4.0 Total comprehensive income 2.7 3.6 0.5 1.8 0.7 Tax Rate (% of PBT) 45 (17) 37 38-45 2 GWM/Edelweiss Investment Research

Kirloskar Brothers Ltd. Segmental Analysis INR cr Q4FY17 Q4FY16 %Change Q3FY17 %Change FY17 FY16 %Change Segmental Revenues (INR cr) Project Sectors 174 142 23% 133 30% 458 411 11.6% Product Sectors 421 380 11% 317 33% 1348 1293 4.3% Total Segment Revenue 594 522 14% 450 32% 1806 1703 6.0% Segmental EBIT (INR cr) Project Sectors 13 3 387% 8 68% 14.9-27.5-154.2% Product Sectors 54 58-7% 30 81% 170 172.51-1.6% EBIT 67 60 11% 38 78% 185 145 27.3% Other Un-allocable Expenditure 29 36-19% 26 14% 100 99.41 0.5% EBIT(including unallocable) 38 24 56% 12 218% 85 46 85.8% Less : Interest 7 11-35% 9-18% 31.5 38.18-17.5% Net Profit/Loss Before Tax 31 13 128% 3 830% 53 7 614.5% EBIT Margins Project Sectors 7.5% 1.9% 5.8% 3.2% -6.7% 0.0% Product Sectors 12.8% 15.2% 9.4% 12.6% 13.3% 0.0% EBIT(including unallocable) 6.3% 4.6% 2.6% 4.7% 2.7% 0.0% Change in Estimates - Consolidated Changes in estimates are mainly due to improved profitability of projects vertical and better growth prospects in the domestic market FY18e FY19e INR Cr Previous New Deviation Previous New Deviation Revenue 2960 2859-3.4% 3244 3146-3.0% EBIDTA 204 229 12.2% 308 333 8.0% PAT 80 82 2.7% 160 163 1.9% 3 GWM/Edelweiss Investment Research

(INR cr) Kirloskar Brothers Ltd. Significant order wins during the quarter in domestic business: Orders inflow growing stronger 600 550 500 450 400 350 300 250 200 Q1FY13 Q2FY13 Q3FY13 Q4FY13 Q1FY14 Q2FY14 Q3FY14 Q4FY14 Q1FY15 Q2FY15 Q3FY15 Q4FY15 Q1FY16 Q2FY16 Q3FY16 Q4FY16 Q1FY17 Q2FY17 Q3FY17 Q4FY17 Major order wins: a) Irrigation sector Domestic - Large pump orders for Penganga, Yettinahole LIS, Garoth, and Mohanpura LIS International EPC orders from Senegal and Suriname worth USD 45 combined to be executed over next 2-3 years funded under Indian government backed Letter of Credit (LC) b) Power sector- - Boiler feed pump for 700MW for NTPC - Boiler feed pump Combined cycle power plant for 400MW in Bangadesh - The company is upbeat about newly announced 11 projects of new nuclear reactors each one of 700MW entailing capex of INR 600bn. KBL has supplied pump in all of the reactors of NPCIL, hence company has the opportunity to grab orders worth INR 600-900cr high margin orders c) Oil & Gas - Kirloskar Ebara s drive turbines got approved by Engineers India which resulted into company receiving order from BHEL for IOC refinery order - The company is eyeing opportunity in domestic refinery sector through both KBL and Kirloskar Ebara for API grade pumps and turbines for BS VI projects 4 GWM/Edelweiss Investment Research

(INR Cr) (INR Cr) Kirloskar Brothers Ltd. International ordering picking up Diversifiying beyond offshore oil 1400 Lower oil price continues to keep OB below historical Order booking diversifying beyond offshore oil 1200 350 1000 300 800 250 600 200 400 150 200 100 0 FY13 FY14 FY15 FY16 FY17 Orders received Order backlog 50 0 Q1FY16 Q2FY16 Q3FY16 Q4FY6 Q1FY17 Q2FY17 Q3FY17 Q4FY17 SPP UK, has diversified beyond offshore oil and gas, in onshore oil & gas, desalination, chemicals, and other process industries in last 2 years. The UK branch has made operational profits but got impacted because of BREXIT related pound depreciation suffering INR 12 cr loss which will be reversed as and when orders are delivered in next 3 months. SPP USA has been a leader in packaged firefighting pumps and has contiinued to see the momentum. Thailand operations have seen traction this year, by growing at >50% on yoy basis. KBL is aggressively expanding in South East Asia wherein team has been brought from Flowserve. Rodelta and SPP Africa has been loss making and is expected to take atleast two years to turn around. The management is confident on turning around overall international operations into profitability of 2013-14 levels ie OPM of 7-8% by 2019-20. 5 GWM/Edelweiss Investment Research

Kirloskar Brothers Ltd. Financials Income statement (Consolidated) (INR cr) Balance sheet (INR cr) Ratios Year to March FY15 FY16 FY17 FY18E FY19E As on 31st March FY15 FY16 FY17 FY18E FY19E Year to March FY15 FY16 FY17 FY18E FY19E Income from operations 2728 2594 2471 2859 3146 Equity share capital 16 16 16 16 16 ROAE (%) 4.5-3.2 6.1 7.8 14.2 Direct costs 1481 1402 1175 1472 1556 Preference Share Capital 0 0 0 0 0 ROACE (%) 7.2-0.9 6.9 10.4 18.1 Employee costs 416 440 469 478 521 Reserves & surplus 996 952 1,014 1,072 1,187 Debtors (days) 105 92 92 92 92 Other expenses 640 687 669 680 736 Shareholders funds 1,012 968 1,030 1,088 1,203 Current ratio 1.6 1.6 1.8 1.7 1.7 Total operating expenses 2537 2529 2313 2630 2813 Secured loans 268 298 302 247 114 Debt/Equity 0.4 0.4 0.4 0.3 0.1 EBITDA 190 65 158 229 333 Unsecured loans 95 81 83 68 31 Inventory (days) 45 52 52 52 52 Depreciation and amortisation 95 77 65 86 89 Borrowings 363 379 385 315 145 Payable (days) 142 135 135 135 135 EBIT 96-12 93 143 244 Minority interest 4 3 3 3 3 Cash conversion cycle (days) 9 9 9 9 9 Interest expenses 50 52 45 29 12 Sources of funds 1,378 1,350 1,418 1,406 1,351 Debt/EBITDA 1.9 5.8 2.4 1.4 0.4 Other income 17 30 31 10 15 Gross block 1,041 1,098 1,158 1,218 1,278 Adjusted debt/equity 0.3 0.3 0.1 0.1 0.0 Profit before tax 63-34 79 124 247 Depreciation 470 534 599 685 774 Provision for tax 17-2 18 42 84 Net block 571 565 560 534 504 Valuation parameters Core profit 45-32 61 82 163 Capital work in progress 12 7 0 0 0 Year to March FY15 FY16 FY17 FY18E FY19E Extraordinary items -1 0 0 0 0 Total fixed assets 583 572 560 534 504 Diluted EPS (INR) 5.6 (4.1) 7.7 10.3 20.5 Profit after tax 44-33 61 82 163 Unrealised profit 0 0 0 0 0 Y-o-Y growth (%) (32.2) NA (287.7) 34.2 98.5 Share from associates 0 0 0 0 0 Investments 0 0 0 0 0 CEPS (INR) 18 6 16 21 32 Adjusted net profit 44-33 61 82 163 Inventories 339 370 353 408 449 Diluted P/E (x) 45.4 NA 33.0 24.6 12.4 Sundry debtors 788 654 623 721 793 Price/BV(x) 2.0 2.1 2.0 1.9 1.7 Equity shares outstanding (mn) 7.9 7.9 7.9 7.9 7.9 Cash and equivalents 64 61 297 220 128 EV/Sales (x) 0.8 0.9 0.9 0.7 0.6 EPS (INR) basic 5.6-4.1 7.7 10.3 20.5 Loans and advances 568 570 543 628 691 EV/EBITDA (x) 12.2 35.7 13.3 9.2 6.1 Diluted shares (Cr) 7.9 7.9 7.9 7.9 7.9 Other current assets 0 0 0 0 0 Diluted shares O/S 7.9 7.9 7.9 7.9 7.9 EPS (INR) fully diluted 5.6-4.1 7.7 10.3 20.5 Total current assets 1,758 1,656 1,816 1,978 2,062 Basic EPS 5.6 (4.1) 7.7 10.3 20.5 Dividend per share 0.5 0.7-0.1 3.1 6.1 Sundry creditors and others 1,059 962 916 1,060 1,167 Basic PE (x) 45.4 NA 33.0 24.6 12.4 Dividend payout (%) 9.0 NA NA 25.0 25.0 Provisions 58 70 74 78 82 Dividend yield (%) 0.2 0.3 (0.0) 1.0 2.0 Total CL & provisions 1,117 1,033 990 1,138 1,248 Common size metrics- as % of net revenues Net current assets 641 624 826 839 814 Year to March FY15 FY16 FY17 FY18E FY19E Net Deferred tax 16 25 33 33 33 Operating expenses 93.0 97.5 93.6 92.0 89.4 Misc expenditure 138 129 0 0 0 Depreciation 3.5 3.0 2.6 3.0 2.8 Uses of funds 1,378 1,350 1,418 1,406 1,351 Interest expenditure 1.8 2.0 1.8 1.0 0.4 Book value per share (INR) 127 122 130 137 151 EBITDA margins 7.0 2.5 6.4 8.0 10.6 Net profit margins 1.6 (1.3) 2.5 2.9 5.2 Cash flow statement (INR cr) Year to March FY15 FY16 FY17 FY18E FY19E Growth metrics (%) Net profit 46-32 61 82 163 Year to March FY15 FY16 FY17 FY18E FY19E Add: Depreciation 95 77 65 86 89 Revenues 1.4 (4.9) (4.8) 15.7 10.0 Add: Misc expenses written off 17 8 129 0 0 EBITDA (4.5) (65.7) 142.3 44.7 45.4 Add: Deferred tax -14-9 -7 0 0 PBT (40.6) NA (335.6) 56.8 98.5 Gross cash flow 143 45 248 168 252 Net profit (30.8) NA (290.3) 34.2 98.5 Less: Changes in W. C. 72-15 -34 91 66 EPS (32.2) NA (287.7) 34.2 98.5 Operating cash flow 71 60 282 77 186 Less: Capex 125 66 53 60 60 Free cash flow -54-6 229 17 126 6 GWM/Edelweiss Investment Research

Jan-13 Mar-13 May-13 Jul-13 Sep-13 Nov-13 Jan-14 Mar-14 May-14 Jul-14 Sep-14 Nov-14 Jan-15 Mar-15 May-15 Jul-15 Sep-15 Nov-15 Jan-16 Mar-16 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 Kirloskar Brothers Ltd. Edelweiss Broking Limited, 1st Floor, Tower 3, Wing B, Kohinoor City Mall, Kohinoor City, Kirol Road, Kurla(W) Board: (91-22) 4272 2200 Vinay Khattar Head Research vinay.khattar@edelweissfin.com Rating Buy Hold Reduce Expected to appreciate more than 15% over a 12-month period appreciate between 5-15% over a 12-month period Return below 5% over a 12-month period Kirloskar Brothers 5 years price chart 350 300 250 200 150 100 50 0 7 GWM/Edelweiss Investment Research

Disclaimer Edelweiss Broking Limited ( EBL or Research Entity ) is regulated by the Securities and Exchange Board of India ( SEBI ) and is licensed to carry on the business of broking, depository services and related activities. The business of EBL and its Associates (list available on www.edelweissfin.com) are organized around five broad business groups Credit including Housing and SME Finance, Commodities, Financial Markets, Asset Management and Life Insurance. Broking services offered by Edelweiss Broking Limited under SEBI Registration No.: INZ000005231; Name of the Compliance Officer: Mr. Dhirendra Rautela, Email ID: complianceofficer.ebl@edelweissfin.com Corporate Office: Edelweiss House, Off CST Road, Kalina, Mumbai - 400098; Tel. (022) 4009 4400/ 4088 5757/4088 6278 This Report has been prepared by Edelweiss Broking Limited in the capacity of a Research Analyst having SEBI Registration No.INH000000172 and distributed as per SEBI (Research Analysts) Regulations 2014. This report does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. The information contained herein is from publicly available data or other sources believed to be reliable. This report is provided for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult his own advisors to determine the merits and risks of such investment. The investment discussed or views expressed may not be suitable for all investors. This information is strictly confidential and is being furnished to you solely for your information. This information should not be reproduced or redistributed or passed on directly or indirectly in any form to any other person or published, copied, in whole or in part, for any purpose. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject EBL and associates / group companies to any registration or licensing requirements within such jurisdiction. The distribution of this report in certain jurisdictions may be restricted by law, and persons in whose possession this report comes, should observe, any such restrictions. The information given in this report is as of the date of this report and there can be no assurance that future results or events will be consistent with this information. This information is subject to change without any prior notice. EBL reserves the right to make modifications and alterations to this statement as may be required from time to time. EBL or any of its associates / group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. EBL is committed to providing independent and transparent recommendation to its clients. Neither EBL nor any of its associates, group companies, directors, employees, agents or representatives shall be liable for any damages whether direct, indirect, special or consequential including loss of revenue or lost profits that may arise from or in connection with the use of the information. Our proprietary trading and investment businesses may make investment decisions that are inconsistent with the recommendations expressed herein. Past performance is not necessarily a guide to future performance.the disclosures of interest statements incorporated in this report are provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. The information provided in these reports remains, unless otherwise stated, the copyright of EBL. All layout, design, original artwork, concepts and other Intellectual Properties, remains the property and copyright of EBL and may not be used in any form or for any purpose whatsoever by any party without the express written permission of the copyright holders. EBL shall not be liable for any delay or any other interruption which may occur in presenting the data due to any reason including network (Internet) reasons or snags in the system, break down of the system or any other equipment, server breakdown, maintenance shutdown, breakdown of communication services or inability of the EBL to present the data. In no event shall EBL be liable for any damages, including without limitation direct or indirect, special, incidental, or consequential damages, losses or expenses arising in connection with the data presented by the EBL through this report. We offer our research services to clients as well as our prospects. Though this report is disseminated to all the customers simultaneously, not all customers may receive this report at the same time. We will not treat recipients as customers by virtue of their receiving this report. EBL and its associates, officer, directors, and employees, research analyst (including relatives) worldwide may: (a) from time to time, have long or short positions in, and buy or sell the securities thereof, of company(ies), mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company/company(ies) discussed herein or act as advisor or lender/borrower to such company(ies) or have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report or at the time of public appearance. EBL may have proprietary long/short position in the above mentioned scrip(s) and therefore should be considered as interested. The views provided herein are general in nature and do not consider risk appetite or investment objective of any particular investor; readers are requested to take independent professional advice before investing. This should not be construed as invitation or solicitation to do business with EBL. EBL or its associates may have received compensation from the subject company in the past 12 months. EBL or its associates may have managed or co-managed public offering of securities for the subject company in the past 12 months. EBL or its associates may have received compensation for investment banking or merchant banking or brokerage services from the subject company in the past 12 months. EBL or its associates may have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past 12 months. EBL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report. Research analyst or his/her relative or EBL s associates may have financial interest in the subject company. EBL, its associates, research analyst and his/her relative may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report or at the time of public appearance. Participants in foreign exchange transactions may incur risks arising from several factors, including the following: ( i) exchange rates can be volatile and are subject to large fluctuations; ( ii) the value of currencies may be affected by numerous market factors, including world and national economic, political and regulatory events, events in equity and debt markets and changes in interest rates; and (iii) currencies may be subject to devaluation or government imposed exchange controls which could affect the value of the currency. Investors in securities such as ADRs and Currency Derivatives, whose values are affected by the currency of an underlying security, effectively assume currency risk. Research analyst has served as an officer, director or employee of subject Company: No EBL has financial interest in the subject companies: No EBL s Associates may have actual / beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report. Research analyst or his/her relative has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report: No EBL has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report: No Subject company may have been client during twelve months preceding the date of distribution of the research report. There were no instances of non-compliance by EBL on any matter related to the capital markets, resulting in significant and material disciplinary action during the last three years. 8 GWM/Edelweiss Investment Research

Disclaimer A graph of daily closing prices of the securities is also available at www.nseindia.com Analyst Certification: The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. Additional Disclaimer for U.S. Persons Edelweiss is not a registered broker dealer under the U.S. Securities Exchange Act of 1934, as amended (the 1934 act ) and under applicable state laws in the United States. In addition Edelweiss is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by Edelweiss, including the products and services described herein are not available to or intended for U.S. persons. This report does not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services and/or shall not be considered as an advertisement tool. "U.S. Persons" are generally defined as a natural person, residing in the United States or any entity organized or incorporated under the laws of the United States. US Citizens living abroad may also be deemed "US Persons" under certain rules. Transactions in securities discussed in this research report should be effected through Edelweiss Financial Services Inc. Additional Disclaimer for U.K. Persons The contents of this research report have not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 ("FSMA"). In the United Kingdom, this research report is being distributed only to and is directed only at (a) persons who have professional experience in matters relating to investments falling within Article 19(5) of the FSMA (Financial Promotion) Order 2005 (the Order ); (b) persons falling within Article 49(2)(a) to (d) of the Order (including high net worth companies and unincorporated associations); and (c) any other persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as relevant persons ). This research report must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this research report relates is available only to relevant persons and will be engaged in only with relevant persons. Any person who is not a relevant person should not act or rely on this research report or any of its contents. This research report must not be distributed, published, reproduced or disclosed (in whole or in part) by recipients to any other person. Additional Disclaimer for Canadian Persons Edelweiss is not a registered adviser or dealer under applicable Canadian securities laws nor has it obtained an exemption from the adviser and/or dealer registration requirements under such law. Accordingly, any brokerage and investment services provided by Edelweiss, including the products and services described herein, are not available to or intended for Canadian persons. This research report and its respective contents do not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services. Disclosures under the provisions of SEBI (Research Analysts) Regulations 2014 (Regulations) Edelweiss Broking Limited ("EBL" or "Research Entity") is regulated by the Securities and Exchange Board of India ("SEBI") and is licensed to carry on the business of broking, depository services and related activities. The business of EBL and its associates are organized around five broad business groups Credit including Housing and SME Finance, Commodities, Financial Markets, Asset Management and Life Insurance. There were no instances of non-compliance by EBL on any matter related to the capital markets, resulting in significant and material disciplinary action during the last three years. This research report has been prepared and distributed by Edelweiss Broking Limited ("Edelweiss") in the capacity of a Research Analyst as per Regulation 22(1) of SEBI (Research Analysts) Regulations 2014 having SEBI Registration No.INH000000172. 9 GWM/Edelweiss Investment Research